Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells

  • Kim, Eun-Bin
  • Jeon, Hye-Yoon
  • Ouh, Yung-Taek
  • Lee, Ah -Jun
  • Moon, Chan-Hee
  • ... Na, Sung Hun
  • 외 1명
Citations

WEB OF SCIENCE

4
Citations

SCOPUS

3

초록

Proinsulin C-peptide, a biologically active polypeptide released from pancreatic 8 -cells, is known to prevent hyperglycemia-induced microvascular leakage; however, the role of C-peptide in migration and invasion of cancer cells is unknown. Here, we investigated high glucose-induced migration and invasion of ovarian cancer cells and the inhibitory effects of human C-peptide on metastatic cellular responses. In SKOV3 human ovarian cancer cells, high glucose conditions activated a vicious cycle of reactive oxygen species (ROS) generation and transglutaminase 2 (TGase2) activation through elevation of intracellular Ca2+ levels. TGase2 played a critical role in high glucose-induced ovarian cancer cell migration and invasion through 8-catenin disassembly. Human C-peptide inhibited high glucose-induced disassembly of adherens junctions and ovarian cancer cell migration and invasion through inhibition of ROS generation and TGase2 activation. The preventive effect of C-peptide on high glucose-induced ovarian cancer cell migration and invasion was further demonstrated in ID8 murine ovarian cancer cells. Our findings suggest that high glucose conditions induce the migration and invasion of ovarian cancer cells, and human C-peptide inhibits these metastatic responses by preventing ROS generation, TGase2 activation, and subsequent disassembly of adherens junctions.

키워드

C-peptideHigh glucoseInvasionMigrationOvarian cancerTransglutaminase 2TRANSGLUTAMINASE 2ENDOTHELIAL APOPTOSISDIABETES-MELLITUSPROSTATE-CANCERRISKASSOCIATIONREPLACEMENTTHERAPY
제목
Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells
저자
Kim, Eun-BinJeon, Hye-YoonOuh, Yung-TaekLee, Ah -JunMoon, Chan-HeeNa, Sung HunHa, Kwon-Soo
DOI
10.1016/j.biopha.2024.116232
발행일
2024-03
유형
Article
저널명
Biomedicine & Pharmacotherapy
172